Literature DB >> 22570165

Effects of Levetiracetam on neural tube development and closure of the chick embryos in ovo.

Füsun Demirçivi Ozer1, Adıgüzel Demirel, Ozlem Yılmaz Dilsiz, Murat Aydın, Nail Özdemir, Yiğit Uyanıkgil, Meral Baka.   

Abstract

PURPOSE: Effects of Levetiracetam (LEV) within its therapeutic range at a 50 mg/kg dose for the chick embryo in ovo has been studied in order to demonstrate whether LEV would effect neural tube closure at the macroscopic morphology or LEV administered embryos still encounter neuroglial detrimental effects at the histological level.
METHODS: Embryos were randomly seperated into control (n = 20) and study (n = 20) groups. The eggshell was windowed at specifically 24 h of incubation, and area underlying the membrane was excised to allow injection with 4.5 μl LEV in the study group, while physiologic saline (0.045 ml) were injected in the control group and each egg were re-incubated for 48 h more. Then, histological and immunohistochemical evaluation of the subjects were done.
RESULTS: Macroscopic evaluation revealed immaturity of the placental vessel network in number and width for the study group in comparison to the controls. Defects of migration, decrease in the crista neuralis content, delay of the basal plates structures in the formation of the usual configuration, and delay in the cellular proliferation and the delay of development for the central nervous system were determined in the LEV-exposed group. Immunostaining of S100 proteins in this study has clearly demonstrated increased expression patterns of both neuroglial and neuronal cell populations. Toluidine blue stainings revealed mostly bipolar, differentiating neurons and crista neuralis cells which is concordant with active migration and differentiation.
CONCLUSIONS: LEV found that delay in the closure of the neural tube and microcephalic fetuses disturb further morphological, biochemical, and functional development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570165     DOI: 10.1007/s00381-012-1758-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  31 in total

Review 1.  Developmental genetics of vertebrate glial-cell specification.

Authors:  David H Rowitch; Arnold R Kriegstein
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

3.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

4.  Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.

Authors:  J van Dieck; T Brandt; D P Teufel; D B Veprintsev; A C Joerger; A R Fersht
Journal:  Oncogene       Date:  2010-02-08       Impact factor: 9.867

5.  Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain.

Authors:  Daniela Manthey; Stella Asimiadou; Vanya Stefovska; Angela M Kaindl; Jessica Fassbender; Chrysanthy Ikonomidou; Petra Bittigau
Journal:  Exp Neurol       Date:  2005-06       Impact factor: 5.330

6.  Transplacental passage of oxcarbazepine and its metabolites in vivo.

Authors:  P Myllynen; P Pienimäki; P Jouppila; K Vähäkangas
Journal:  Epilepsia       Date:  2001-11       Impact factor: 5.864

Review 7.  Levetiracetam use in pregnancy.

Authors:  Brian Longo; Alicia B Forinash; Julie A Murphy
Journal:  Ann Pharmacother       Date:  2009-08-18       Impact factor: 3.154

8.  Preliminary results on pregnancy outcomes in women using lamotrigine.

Authors:  Patricia Tennis; R R Eldridge
Journal:  Epilepsia       Date:  2002-10       Impact factor: 5.864

9.  Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy.

Authors:  Jinsook Kim; Alexei Kondratyev; Karen Gale
Journal:  J Pharmacol Exp Ther       Date:  2007-07-16       Impact factor: 4.030

10.  Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother.

Authors:  P Bülau; W D Paar; G E von Unruh
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more
  1 in total

1.  Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.

Authors:  Ahmad Chitsaz; Noushin Mehrbod; Masoud Etemadifar; Mohamadreza Najafi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.